Melanie Gloria sold $679K of Immunovant (IMVT)

Executed Jun 26, disclosed Jun 26, the same day.

Value, as filed

$679K

17,714 sh across 2 lots

Executed

Jun 26

the trade date, as filed

Disclosed

Jun 26

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Melanie Gloria Chief Operating Officer profile →

Melanie Gloria (Chief Operating Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Immunovant, Inc. (IMVT). The largest single filing was $679K of IMVT (17,714 sh across 2 lots, as filed), executed Jun 26.

The name

IMVT

Immunovant, Inc. IMVT · Healthcare · 35 filings in 24 months ticker →

Healthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Melanie Gloria in IMVT

IMVTSALE Immunovant, Inc. $135K
3,056 sh × $44.16
Exec Aug 20
Filed Aug 21 · 4:03 PM ET IMVTSALE Immunovant, Inc. $217K
8,722 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET IMVTSALE Immunovant, Inc. $241K
10,251 sh × $23.54
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET